Journals / Türk Nöroloji Dergisi / 2010 / Cilt: 16 - Sayı: 3

POEMS syndrome: Case report

POEMS sendromu: Olgu sunumu

Pages
159–162
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This rare syndrome should be included in the differential diagnosis of acquired neuropathies associated with multisystemic manifestations.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Presented with characteristic polyneuropathy and multisystemic manifestations, POEMS syndrome is a rare plasma cell disorder.
📊
Key Findings & Data:Vascular endothelial growth factor, secreted by plasmacytoma, is considered responsible for these symptoms.
💡
Conclusion & Impact:This rare syndrome should be included in the differential diagnosis of acquired neuropathies associated with multisystemic manifestations.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Presented with characteristic polyneuropathy and multisystemic manifestations, POEMS syndrome is a rare plasma cell disorder. Vascular endothelial growth factor, secreted by plasmacytoma, is considered responsible for these symptoms. The first symptoms in this patient were arthralgia, distal sensory impairment ascending proximally and motor impairment of distal lower extremities. By immunoelectrophoresis, M protein in serum and urine was detected. In addition to polyneuropathy and monoclonal gammopathy, the patient presented with organomegaly, endocrine dysfunction and skin changes, and was diagnosed as POEMS syndrome. This rare syndrome should be included in the differential diagnosis of acquired neuropathies associated with multisystemic manifestations.

Özet

POEMS sendromu, polinöropati ve multisistemik tutulum ile seyreden oldukça ender görülen bir plazma hücre diskrazisidir. Semptomlardan plazmasitom tarafından salgılanan vasküler endotelyal büyüme faktörü sorumlu tutulmaktadır. Distal simetrik sensörimotor polinöropati kliniği ile başvuran, yanı sıra organomegali, endokrin bozukluk ve deri değişiklikleri de olan olgunun immünelektroforezinde serum ve idrarda M proteini saptanması nedeniyle POEMS sendromu düşünülmüştür. Edinsel nöropatilerin ayırıcı tanısında akla gelmesi gereken bu sendrom ender görülmesi nedeniyle sunulmuştur.

🔖

Cite This Article

OCAKÇI, S., KÖŞKDERELİOĞLU, A., AHMEDOV, R., GERÇEKER, B., GÖKÇAY, A., GÖKÇAY, F. (2022). POEMS syndrome: Case report. Türk Nöroloji Dergisi, Cilt: 16 - Sayı: 3, 159–162. https://ajindex.com/articles/636975

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR, et al. POEMS syndrome: definitions and long-term outcome. Blood 2003;101:2496-506
  2. Leite AC, Nascimento OJ, Lima MA, Andrada-Serpa MJ. Arq NeuroPsiquiatr 2007;65:516-20
  3. Soubrier MJ, Dubost JJ, Sauvezie BJ. POEMS syndrome: a study of 25 cases and a review of the literature. French Study Group on POEMS syndrome. Am J Med 1994;97:543-53
  4. Kamezaki K, Nagafuji K. POEMS syndrome: monoclonal plasma cell disorder with polyneuropathy. Nippon Rinsho 2007;65:2235-7
  5. Dispenzieri A. POEMS syndrome. Blood Rev 2007;21:285-99
  6. Dispenzieri A, Lacy MQ, Hayman SR, Kumar SK, Buadi F, Dingli D, et al. Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome. Eur J Haematol 2008;80:397-406
  7. Kastris E, Terpos E, Anagnostopoulos A, Xilouri I, Dimopoulos MA. Angiogenetic factors and biochemical markers of bone metabolism in POEMS syndrome treated with high dose therapy and autologous stem cell support. Clin Lymphoma Myeloma 2006;7:73-6
  8. Soubrier M, Dubost JJ, Serre AF, Ristori JM, Sauvezie B, Cathebras P, et al. Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor. Arthritis Rheum 1997;40:786-7
  9. Dispenzieri A. POEMS syndrome. Hematology Am Soc Hematol Educ Program 2005:360-7
  10. Dispenzieri A, Suarez GA, Kyle RA. POEMS syndrome (osteosclerotic myeloma). In: Dyck PJ, Thomas PK (eds). Peripheral Neuropathy. 4th ed. Philadelphia PA: Elsevier Sanders, 2005:2453-69
  11. Rajkumar SV, Dispenzieri A, Kyle RA. Monoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, Al amyloidosis, and related plasma cell disorders: diagnosis and treatment. Mayo Clin Proc 2006;81:693-703
  12. Gandhi GY, Basu R, Dispenzieri A, Basu A, Montori VM, Brennan MD. Endocrinopathy in POEMS syndrome: the Mayo Clinic experience. Mayo Clin Proc 2007;82:836-42
  13. Caramaschi P, Biasi D, Lestani M, Chilosi M. A case of acquired partial lipodystrophy associated with POEMS syndrome. Rheumatology 2003;42:488 90
  14. Vourch’h-Jourdain M, Clairand R, Masseau A, Barbarot S, Hamidou M. Partial lipodystrophy and POEMS syndrome: a case report. Ann Dermatol Venereol 2008;135:773-5.